Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
about
Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistanceMarkers of iron status in chronic kidney disease.What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: How Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors May Change Iron Management in End-Stage Renal Disease.Intravenous Irons: From Basic Science to Clinical PracticeImpact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney DiseaseHepcidin as a potential predictor for preoperative anemia treatment with intravenous iron-A retrospective pilot study
P2860
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hepcidin Response to Iron Ther ...... Analysis of the FIND-CKD Trial
@ast
Hepcidin Response to Iron Ther ...... Analysis of the FIND-CKD Trial
@en
type
label
Hepcidin Response to Iron Ther ...... Analysis of the FIND-CKD Trial
@ast
Hepcidin Response to Iron Ther ...... Analysis of the FIND-CKD Trial
@en
prefLabel
Hepcidin Response to Iron Ther ...... Analysis of the FIND-CKD Trial
@ast
Hepcidin Response to Iron Ther ...... Analysis of the FIND-CKD Trial
@en
P2093
P2860
P1433
P1476
Hepcidin Response to Iron Ther ...... Analysis of the FIND-CKD Trial
@en
P2093
Andreas H Bock
Carlo A Gaillard
David B Van Wyck
Fernando Carrera
Iain C Macdougall
Kai-Uwe Eckardt
Maureen Cronin
Simon D Roger
Sukhvinder S Bansal
Sylvain Larroque
P2860
P304
P356
10.1371/JOURNAL.PONE.0157063
P407
P577
2016-06-08T00:00:00Z